These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35972434)

  • 21. Peripheral Retinal Changes Associated with Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 12 by the Age-Related Eye Disease Study 2 Optos PEripheral RetinA (OPERA) Study Research Group.
    ; Domalpally A; Clemons TE; Danis RP; Sadda SR; Cukras CA; Toth CA; Friberg TR; Chew EY
    Ophthalmology; 2017 Apr; 124(4):479-487. PubMed ID: 28089680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallothionein polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
    García M; Álvarez L; Fernández Á; González-Iglesias H; Escribano J; Fernández-Vega B; Villota E; Fernández-Vega Cueto L; Fernández-Vega Á; Coca-Prados M
    Ophthalmic Genet; 2017; 38(5):451-458. PubMed ID: 28635422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular growth factors and cytokines in patients with dry and neovascular age-related macular degeneration.
    Muether PS; Neuhann I; Buhl C; Hermann MM; Kirchhof B; Fauser S
    Retina; 2013 Oct; 33(9):1809-14. PubMed ID: 23492946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
    Sobrin L; Ripke S; Yu Y; Fagerness J; Bhangale TR; Tan PL; Souied EH; Buitendijk GH; Merriam JE; Richardson AJ; Raychaudhuri S; Reynolds R; Chin KA; Lee AY; Leveziel N; Zack DJ; Campochiaro P; Smith RT; Barile GR; Hogg RE; Chakravarthy U; Behrens TW; Uitterlinden AG; van Duijn CM; Vingerling JR; Brantley MA; Baird PN; Klaver CC; Allikmets R; Katsanis N; Graham RR; Ioannidis JP; Daly MJ; Seddon JM
    Ophthalmology; 2012 Sep; 119(9):1874-85. PubMed ID: 22705344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Developments in the Treatment of Wet Age-related Macular Degeneration.
    Papadopoulos Z
    Curr Med Sci; 2020 Oct; 40(5):851-857. PubMed ID: 32980899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration.
    García M; Álvarez L; Nogacka AM; González-Iglesias H; Escribano J; Fernández-Vega B; Fernández-Vega Á; Fernández-Vega L; Coca-Prados M
    Acta Ophthalmol; 2015 Dec; 93(8):e658-66. PubMed ID: 26152901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules.
    Nebbioso M; Lambiase A; Cerini A; Limoli PG; La Cava M; Greco A
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration.
    Cipriani V; Hogg RE; Sofat R; Moore AT; Webster AR; Yates JRW; Fletcher AE;
    JAMA Ophthalmol; 2017 Sep; 135(9):909-916. PubMed ID: 28750115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dry Age-Related Macular Degeneration Pharmacology.
    Wright CB; Ambati J
    Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current drug and molecular therapies for the treatment of atrophic age-related macular degeneration: phase I to phase III clinical development.
    Li H; Chintalapudi SR; Jablonski MM
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1103-1114. PubMed ID: 28816076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of systemic drugs on the development and progression of age-related macular degeneration.
    Grimes KR; Aloney A; Skondra D; Chhablani J
    Surv Ophthalmol; 2023; 68(3):332-346. PubMed ID: 36731638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
    ; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
    JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis.
    Fisher DE; Klein BE; Wong TY; Rotter JI; Li X; Shrager S; Burke GL; Klein R; Cotch MF
    Ophthalmology; 2016 Jun; 123(6):1297-308. PubMed ID: 26896123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonneovascular Age-Related Macular Degeneration.
    Michels S; Garhöfer G
    Dev Ophthalmol; 2016; 55():112-24. PubMed ID: 26502209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
    Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
    Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials.
    Kumar-Singh R
    Exp Eye Res; 2019 Jul; 184():266-277. PubMed ID: 31082363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration.
    ElShelmani H; Brennan I; Kelly DJ; Keegan D
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Towards the new spectral-domain optical coherence tomography based classification of age-related macular degeneration].
    Gallego-Pinazo R; Dolz-Marco R; Díaz-Llopis M
    Arch Soc Esp Oftalmol; 2012 Aug; 87(8):247-52. PubMed ID: 22794171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration.
    Wang SV; Kulldorff M; Poor S; Rice DS; Banks A; Li N; Lii J; Gagne JJ
    Ophthalmology; 2021 Feb; 128(2):248-255. PubMed ID: 32777229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-33trap-mediated IL-33 neutralization does not exacerbate choroidal neovascularization, but fails to protect against retinal degeneration in a dry age-related macular degeneration model.
    Van Hove I; Van Bergen T; Etienne I; Holgado A; Afonina IS; Beyaert R; Feyen JH; Hu TT
    Exp Eye Res; 2021 Jun; 207():108608. PubMed ID: 33930400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.